U

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

Key Account Manager Sr. / Omaha

Field SalesUpdated on Nov 14
Full-timeOmaha, NE, USA$160k - $210k /yr

About the Job

Requirements

  • A bachelor's degree (BA/BS) is required.
  • At least 7 years of biotechnology or biopharmaceutical sales experience is required.
  • At least 4 years of experience selling rare disease therapies is required.
  • A proven, documented track record of delivering consistent sales results is required.
  • Experience calling on customers at academic centers, community-based hospitals, and private practice offices, both in person and virtually, is required.
  • Working knowledge of local managed care reimbursement is required.

Responsibilities

  • Exceed sales objectives by developing and implementing business plans and marketing initiatives.
  • Maximize impact by leveraging available data sets and stakeholder input.
  • Seek qualified leads, profile new accounts, and refine call planning and routing to optimize schedules.
  • Collaborate with medical, reimbursement support, managed market, specialty pharmacy, and other cross-functional partners to communicate customer needs and build and deliver appropriate solutions.
  • Partner with advocacy groups to support patient education and disease-state awareness in the local community.
  • Prioritize budget allocation to meet territory objectives and implement marketing initiatives to achieve sales goals.
  • Maintain accountability and the highest standard of ethical conduct.

Desired Qualifications

  • Experience promoting products specific to central nervous system or neuroscience, including epilepsy.
  • New product launch experience.
  • Specialty pharmacy or Risk Evaluation and Mitigation Strategy (REMS) experience.

About the Company

UCB Pharma

Biopharmaceuticals for neurology and immunology therapies

UCB Pharma focuses on developing treatments for severe diseases in neurology and immunology. It discovers, develops, and commercializes novel molecules and generates products aimed at improving patient lives. The company works by researching and developing therapies, integrating patient insights to guide innovation, and investing over a quarter of revenue into scientific research. Its global presence (about 9,000 employees across 40 countries) and €5.3 billion 2023 revenue reflect its scale and commitment to bringing therapies to patients worldwide. UCB differentiates itself by combining direct patient engagement with substantial R&D investment to address unmet needs in neurology and immunology, aiming to transform lives through science and patient care.

Company size
10,001+
Company stage
IPO
Headquarters
City of Brussels, Belgium
Founded
1928

Recently Posted Jobs

Explore more opportunities at UCB Pharma

See more jobs